OriBase Pharma is an international contract research organization (CRO) specialized in the design and chemistry synthesis of kinase inhibitors, and dedicated to accelerating drug discovery processes. Among others, OriBase Pharma offers products and services through the synthesis of new heterocyclic building blocks and final product libraries. Our products are intended for research purposes in pharmaceutical, biotech and agrochemistry industries. We provide a unique selection of new chemical entities built on organizable scaffolds, intermediates, and libraries.